1-3 of 3
Sinan Dal
Close
Sort by
Journal Articles

Glofitamab in Relapsed/Refractory Diffuse Large B Cell Lymphoma: Real World Data

Burhan Ferhanoglu, Zafer Gulbas, Ant Uzay, Muhit Özcan, Fahir Ozkalemkas, Mehmet Sinan Dal, Hakan Kalyon, Olga Meltem Akay, Burak Deveci, Huseyin Bekoz, Omur Gokmen Sevindik, Tayfur Toptas, Asu Fergun Yilmaz, Derya Koyun, Nihan Alkis, Elif Birtas Atesoglu
Journal: Blood
Blood (2022) 140 (Supplement 1): 6704–6705.
https://doi.org/10.1182/blood-2022-165385
Published: 2022
Journal Articles

Is It Time for Early Cessation of Empirical Antibiotherapy in Patients Presenting with Febrile Neutropenia? Preliminary Results of a Risk-Adapted Approach in a Hematology Clinic

Ali Hakan Kaya, MD, Emre Tekgunduz, MD, Filiz Bekdemir, MD, Hikmetullah Batgi, MD, Tugcenur Yigenoglu, MD, Bahar Uncu Ulu, MD, Bilge Ugur, MD, Dicle Iskender, MD, Merih Kizil Cakar, MD, Mehmet Sinan Dal, MD, Seval Akpinar, MD, Fatih Demirkan, MD, Fevzi Altuntas, MD
Journal: Blood
Blood (2016) 128 (22): 2503.
https://doi.org/10.1182/blood.V128.22.2503.2503
Published: 2016
Journal Articles

Cholesterol Levels In Patients With Newly Diagnosed Chronic Lymphocytic Leukemia: A retrospective Multicenter Study

Irfan Yavasoglu, Gokhan Pektas, Fergün Yilmaz, Gülsüm Akgün, Anil Tombak, Bila Toka, Sinan Dal, Hasan Ozbas, Guven Cetin, Ayhan Donmez, Oktay Bilgir, Naci Tiftik, Sehmuz Ertop, Orhan M. Ayyildiz, MD,, Mehmet Sonmez, M.D., Gurhan Kadikoylu, MD, Murat Tombuloglu, Zahit Bolaman, MD
Journal: Blood
Blood (2013) 122 (21): 5292.
https://doi.org/10.1182/blood.V122.21.5292.5292
Published: 2013